Categories
MSU Bioethics on Facebook
Tweets
- Watch: Covert Costs of Racial and Ethnic Concordance in the Medical Workforce bioethics.msu.edu/90-brownbags/r… 3 hours ago
- From @NEJM: Covid’s Color Line — Infectious Disease, Inequity, and Racial Justice ow.ly/qnYL50ANOSR 7 hours ago
- COVID-19 vs. Childhood Immunization? A Bioethics Perspective from Nigeria msubioethics.com/2020/06/25/chi… #BioethicsInTheNews 1 day ago
- Watch: Intentional Parenthood’s Promise: Redefining Legal Parentage for the 21st Century bioethics.msu.edu/90-brownbags/r…… twitter.com/i/web/status/1… 2 days ago
- Women cannot afford “nice”: The unpaid labor of gendered caregiving msubioethics.com/2020/07/16/unp… #BioethicsInTheNews https://t.co/ZOOBiUHom7 2 days ago
Top Posts & Pages
Archives
Meta
Tag Archives: cancer treatment
Listen: Ethics and Policy Issues of Targeted Cancer Therapies
No Easy Answers in Bioethics Episode 16 What kinds of challenges currently exist within precision medicine? This episode focuses specifically on targeted cancer therapies, featuring a discussion between Center Professor and Acting Director Dr. Len Fleck and College of Osteopathic Medicine student … Continue reading
Health Care and Social Justice: Just Take Two Aspirin for Your Tumor If You Cannot Afford Your Cancer Care
Dr. Stanley Goldfarb is the former Associate Dean of Curriculum at the University of Pennsylvania Perelman School of Medicine. In a recent Wall Street Journal opinion piece, “Take Two Aspirin and Call Me by My Pronouns,” he complained that curricula in medical schools “are increasingly focused on social justice rather than treating illness.” He goes on to say, “A new wave of educational specialists is increasingly influencing medical education. They emphasize ‘social justice’ that is related to health care only tangentially.” Really? Only tangentially? Continue reading
Center faculty present at 20th annual American Society for Bioethics and Humanities conference
Center faculty members Dr. Len Fleck and Dr. Devan Stahl recently presented at the 20th annual American Society for Bioethics and Humanities (ASBH) conference, held October 18-21 in Anaheim, CA. Dr. Fleck presented on “Parsimonious Precision Medicine: Wicked Problems.” The … Continue reading
Drs. Eijkholt and Fleck present at International Bioethics Retreat in Paris
Center Professor Len Fleck and Marleen Eijkholt, former Assistant Professor with the Center, recently presented at the 2018 International Bioethics Retreat, held in Paris, France on June 27-29. The conference has been sponsored by Cambridge University for the past eighteen … Continue reading
Greed Is God: The Divine Right to Avaricious Drug Pricing
This post is a part of our Bioethics in the News series By Leonard M. Fleck, PhD Some recent headlines worth noting: “U.S. Prescription Drug Costs Are a Crime,” “Americans Say They are Suffering as Drug Costs Continue to Rise,” “When … Continue reading
Dr. Fleck presents at Great Lakes Biorepository Research Network annual scientific meeting
Center Professor Len Fleck, PhD, was a keynote speaker at the Great Lakes Biorepository Research Network (GLBRN) Annual Scientific Meeting, held at Beaumont Hospital-Royal Oak Campus on November 3. The title of Dr. Fleck’s presentation was “Precision Medicine, Ethical Ambiguity,” … Continue reading
Just Caring: Health Reform, Cost Control, and the Fate of Children with Life-Altering Illnesses
Center Professor Dr. Leonard Fleck recently gave a keynote address at the 2017 Pediatric Bioethics Day at Norton Children’s Hospital in Louisville, KY, held on September 20. Titled “Just Caring: Health Reform, Cost Control, and the Fate of Children with … Continue reading
Rights and Responsibilities at the End of Life
By Hannah Giunta, MPH, PhD
Questions about end-of-life care are always vexing, but a recent article in U.S. News and World Report suggests that cancer patients continue to receive useless but harmful treatments at the end of life (Thompson, 2016). A new research study presented at the American Society of Clinical Oncology’s (ASCO’s) annual meeting revealed that a big part of the problem comes from a lack of meaningful dialogue among physicians, patients, and family members. Continue reading
Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer
Center Professor Emerita Dr. Margaret Holmes-Rovner is a contributing author on a new article published in Annals of Family Medicine, “Patients’ Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.” Published in the May/June 2016 issue, the study is … Continue reading
Posted in Articles, Publications, Uncategorized
Tagged Annals of Family Medicine, bioethics, cancer, cancer treatment, Margaret Holmes-Rovner, prostate cancer
Precision Medicine/Ambiguous Ethics?
This post is a part of our Bioethics in the News series. For more information, click here. By Leonard Fleck, PhD In his State of the Union Address President Obama announced that he wished to set aside $215 million for his … Continue reading
Posted in Bioethics in the News
Tagged cancer, cancer treatment, genome, Imatinib, Leonard Fleck, precision medicine
11 Comments
